CellBion Co., Ltd.

₩11,520As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:308430Healthcare
Country South Korea
PE (Fwd) •••
TSR 2Y CAGR (12.51%)
Div yield —
ROE 24.79%
Pharmaceutical Preparations
Beta (5Y) (0.06)
PE TTM 19.50
TSR TTM (28.45%)
Mkt cap ₩148.7B
ROIC (12.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩14,241
23.62%
(62.14%)
Hold 1|7|11|12|1
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
206.71
225.91
233.29
225.45
(3.54%)
0.95%
7.91%
7.51%
Revenue₩B
8.332
8.203
8.330
8.191
16.97%
8.71%
4.33%
(0.58%)
Peers (US$109.6M)
Cap (US$)
PE
108.9M
4.295x
110.9M
9.556x
Capital
TTM
5Y
10Y
Leveragex
0.380
(0.064)
(0.074)
EBIT/Intx
0.459
0.151
0.146
Own earn%
(21.20)
(59.01)
(60.42)
Sh yield%
25.40
29.44
26.58
Owners
Insiders/Inst%
9.25
56.65
Short interest%
2.86
SBC / revenue%
5.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
13–16
$1 testx
0.0
Incr. ROIC%
31